Delivery Order SPE2DB22D1106-SPE2DB24FFFH6
Award Date
8/2/24
Potential Completion Date
8/5/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,182.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Boostrix TDAP vaccine syringes, 0.5 ml, with a performance period through May 8, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP vaccine syringes. The contract has a ceiling value of $2,592.50 and an ultimate completion date of June 24, 2024. It is a firm fixed-price contract awarded without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $1,064.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Boostrix TDAP vaccine syringes, 0.5 mL, with an ultimate completion date of April 30, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Boostrix TDAP vaccine syringes, valued at $17,024.64 with a completion date of April 9, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a $4,085.47 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide BOOSTRIX TDAP vaccine syringes. The contract has an ultimate completion date of July 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which enables the DLA to efficiently procure a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BOOSTRIX TDAP vaccine syringes, a critical pharmaceutical product used to support military and government healthcare programs. The firm-fixed-price delivery order has a ceiling value of $2,554.30 and an ultimate completion date of September 19, 2024. This award is part of a...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,149.28 contract is for the delivery of Boostrix TDAP vaccines in 0.5 ML syringes. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product, with a firm fixed price ceiling value of $15,555.94. The contract has an ultimate completion date of May 13, 2025. This appears to be a delivery order contract, without a set-aside designation, indicating open competition....
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the BOOSTRIX TDAP vaccine syringe 0.5mL. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a firm fixed price of $1,063.64. The contract does not have a set-aside designation, indicating it was awarded through open competition. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP vaccine syringes. The contract has a firm fixed price of $13,919.40 and a completion date of July 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows the DLA to efficiently procure a comprehensive range of medical commodities...